Skip to main content
Top
Published in: Molecular and Cellular Pediatrics 1/2020

Open Access 01-12-2020 | Case Study

Mutations of uncertain significance in heterozygous variants as a possible cause of severe short stature: a case report

Authors: Nami Mohammadian Khonsari, Sahar Mohammad Poor Nami, Benyamin Hakak-Zargar, Tessa Voth

Published in: Molecular and Cellular Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Linear bone growth is achieved by the division of chondrocytes at the growth plate and is regulated by endocrine and paracrine factors such as growth hormone. Mutations that negatively affect chondrogenesis can be a contributor to short stature. One such mutation can occur in the ACAN gene, causing short stature and advanced bone age. Similarly, mutations in growth hormone receptors (GHR) can lead to Laron syndrome (LS), one of the several disorders that are collectively called growth hormone insensitivity syndrome (GHI). Another example is Floating-Harbor syndrome (FHS), a rare autosomal dominant due to mutations in the SRCAP gene that can also result in short stature.

Case presentation

We report the case of a 6-year-old female with concomitant mutations in the three genes mentioned above. The mutations reported here were found on genetic studies and are usually benign, causing a variant of undetermined significance. However, our patient’s phenotype could only be explained by the compounded effects of pathogenic mutations of these genes. Some of the same mutations were also found in the patient’s father and her paternal grandfather. Both also presented with short stature, though not to the same degree as our patient. While these mutations are often reported to be insignificant, they gave rise to severe short stature and a specific phenotype in the patient when presented together. We think that even though the GHI spectrum is inherited through an autosomal recessive pattern, the sum of these heterozygous mutations resulted in severe short stature despite the limited GHI seen in our patient, the father, and the grandfather, through a rare ACAN and SRCAP mutation that, to our knowledge, has not been previously reported as a pathogenic mutation in the literature.

Conclusion

We investigated the possible synergistic effects of these variations on exacerbation or masking of the signs and symptoms of GHI with the hope of providing a better understanding of these genes and their function through our rare case.
Literature
1.
go back to reference Baron J et al (2015) Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol 11:735–746CrossRef Baron J et al (2015) Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol 11:735–746CrossRef
2.
go back to reference Roughley PJ, Mort JS (2014) The role of aggrecan in normal and osteoarthritic cartilage. J Exp Orthop 1:8CrossRef Roughley PJ, Mort JS (2014) The role of aggrecan in normal and osteoarthritic cartilage. J Exp Orthop 1:8CrossRef
3.
go back to reference Dateki SJCPE (2017) ACAN mutations as a cause of familial short stature. Clin Pediatr Endocrinol 26:119–125CrossRef Dateki SJCPE (2017) ACAN mutations as a cause of familial short stature. Clin Pediatr Endocrinol 26:119–125CrossRef
4.
go back to reference Quintos JB, Guo MH, Dauber A (2015) Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene. J Pediatr Endocrinol Metab 28:927–932CrossRef Quintos JB, Guo MH, Dauber A (2015) Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene. J Pediatr Endocrinol Metab 28:927–932CrossRef
5.
go back to reference Nilsson O et al (2014) Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations. J Clin Endocrinol Metab 99:E1510–E1518CrossRef Nilsson O et al (2014) Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations. J Clin Endocrinol Metab 99:E1510–E1518CrossRef
6.
go back to reference Fang P et al (2007) Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states. J Clin Endocrinol Metab 92:2223–2231CrossRef Fang P et al (2007) Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states. J Clin Endocrinol Metab 92:2223–2231CrossRef
7.
go back to reference Gent J, Van Kerkhof P, Roza M, Bu G, Strous G (2002) Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858–9863CrossRef Gent J, Van Kerkhof P, Roza M, Bu G, Strous G (2002) Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858–9863CrossRef
8.
go back to reference Rosenfeld RG (1994) Rosenbloom, A.L. & Guevara-Aguirre, J.J.E.r. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369–390CrossRef Rosenfeld RG (1994) Rosenbloom, A.L. & Guevara-Aguirre, J.J.E.r. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369–390CrossRef
9.
go back to reference Goddard AD et al (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. N Engl J Med 333:1093–1098CrossRef Goddard AD et al (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. N Engl J Med 333:1093–1098CrossRef
10.
go back to reference Kaji H et al (1997) Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. J Clin Endocrinol Metab 82:3705–3709PubMed Kaji H et al (1997) Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. J Clin Endocrinol Metab 82:3705–3709PubMed
11.
go back to reference Kou K, Lajara R, Rotwein P (1993) Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome. J Clin Endocrinol Metab 76:54–59PubMed Kou K, Lajara R, Rotwein P (1993) Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome. J Clin Endocrinol Metab 76:54–59PubMed
12.
go back to reference Kaji H, Ohashi S, Abe H, Chihara K (1994) Regulation of the growth hormone (GH) receptor and GH-binding protein mRNA. Proc Soc Exp Biol Med 206:257–262CrossRef Kaji H, Ohashi S, Abe H, Chihara K (1994) Regulation of the growth hormone (GH) receptor and GH-binding protein mRNA. Proc Soc Exp Biol Med 206:257–262CrossRef
13.
go back to reference Chujo S et al (1996) No correlation of growth hormone receptor gene mutation P561T with body height. Eur J Endocrinol 134:560–562CrossRef Chujo S et al (1996) No correlation of growth hormone receptor gene mutation P561T with body height. Eur J Endocrinol 134:560–562CrossRef
14.
go back to reference Moia S et al (2017) Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report. Ital J Pediatr 43:94CrossRef Moia S et al (2017) Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report. Ital J Pediatr 43:94CrossRef
15.
16.
go back to reference Amselem S et al (1993) Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Human Mol Genet 2:355–359CrossRef Amselem S et al (1993) Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Human Mol Genet 2:355–359CrossRef
17.
go back to reference Hood RL et al (2012) Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. Am J Human Genet 90:308–313CrossRef Hood RL et al (2012) Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. Am J Human Genet 90:308–313CrossRef
18.
go back to reference Wieczorek D, Wüsthof A, Harms E, Meinecke P (2001) Floating-Harbor syndrome in two unrelated girls: mild short stature in one patient and effective growth hormone therapy in the other. Am J Med Genet 104:47–52CrossRef Wieczorek D, Wüsthof A, Harms E, Meinecke P (2001) Floating-Harbor syndrome in two unrelated girls: mild short stature in one patient and effective growth hormone therapy in the other. Am J Med Genet 104:47–52CrossRef
19.
go back to reference Cannavo S et al (2002) Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome. J Endocrinol Invest 25:58–64CrossRef Cannavo S et al (2002) Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome. J Endocrinol Invest 25:58–64CrossRef
20.
go back to reference Riazuddin SA, Vasanth S, Katsanis N, Gottsch JD (2013) Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4. Am J Hum Genet 93:758–764CrossRef Riazuddin SA, Vasanth S, Katsanis N, Gottsch JD (2013) Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4. Am J Hum Genet 93:758–764CrossRef
Metadata
Title
Mutations of uncertain significance in heterozygous variants as a possible cause of severe short stature: a case report
Authors
Nami Mohammadian Khonsari
Sahar Mohammad Poor Nami
Benyamin Hakak-Zargar
Tessa Voth
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Molecular and Cellular Pediatrics / Issue 1/2020
Electronic ISSN: 2194-7791
DOI
https://doi.org/10.1186/s40348-020-00104-6

Other articles of this Issue 1/2020

Molecular and Cellular Pediatrics 1/2020 Go to the issue